OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
How BRCA and homologous recombination deficiency change therapeutic strategies in ovarian cancer: a review of literature
Martina Arcieri, Veronica Tius, Claudia Andreetta, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 15
Martina Arcieri, Veronica Tius, Claudia Andreetta, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 15
Showing 15 citing articles:
Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer
Yijun Xie, Di Xiao, Duo Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Yijun Xie, Di Xiao, Duo Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
A comprehensive comparison of PARP inhibitors as maintenance therapy in platinum-sensitive recurrent ovarian cancer: a systematic review and network meta-analysis
Shiya Ji, Lu Chen, Y L Yu, et al.
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access
Shiya Ji, Lu Chen, Y L Yu, et al.
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access
Genomics in Cancer of Unknown Primary – Utility in Modern Clinical Practice
Andrew J. Dooley, Anne Ramsay Bowden, H. Whatling, et al.
Clinical Oncology (2025) Vol. 41, pp. 103793-103793
Closed Access
Andrew J. Dooley, Anne Ramsay Bowden, H. Whatling, et al.
Clinical Oncology (2025) Vol. 41, pp. 103793-103793
Closed Access
Relationship between nutritional-inflammatory markers and postoperative outcomes in ovarian cancer: a retrospective study
Ying Zhang, Xing Wen, Xiaoyi Liang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Ying Zhang, Xing Wen, Xiaoyi Liang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Molecular biology as a driver in therapeutic choices for ovarian cancer
Martina Arcieri, Claudia Andreetta, Veronica Tius, et al.
International Journal of Gynecological Cancer (2024), pp. ijgc-005700
Closed Access | Times Cited: 4
Martina Arcieri, Claudia Andreetta, Veronica Tius, et al.
International Journal of Gynecological Cancer (2024), pp. ijgc-005700
Closed Access | Times Cited: 4
Targeting the DNA damage response in cancer
Guffanti Federica, Chiappa Michela, Giovanna Damia
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 4
Guffanti Federica, Chiappa Michela, Giovanna Damia
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 4
Beyond failure of endocrine-based therapies in HR+/HER2 negative advanced breast cancer: what before chemotherapy? A glimpse into the future.
Rosalba Torrisi, R. Gerosa, Chiara Miggiano, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 208, pp. 104634-104634
Closed Access
Rosalba Torrisi, R. Gerosa, Chiara Miggiano, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 208, pp. 104634-104634
Closed Access
Overview of BH3 mimetics in ovarian cancer
Donatella Del Bufalo, Giovanna Damia
Cancer Treatment Reviews (2024) Vol. 129, pp. 102771-102771
Closed Access | Times Cited: 1
Donatella Del Bufalo, Giovanna Damia
Cancer Treatment Reviews (2024) Vol. 129, pp. 102771-102771
Closed Access | Times Cited: 1
Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer
Sanat Kulkarni, Ketankumar Gajjar, Srinivasan Madhusudan
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Sanat Kulkarni, Ketankumar Gajjar, Srinivasan Madhusudan
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?
Yi Liu, Xiaojun Chen, Huaiwu Lu, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 5, pp. 621-632
Closed Access
Yi Liu, Xiaojun Chen, Huaiwu Lu, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 5, pp. 621-632
Closed Access
Diagnosis, treatment and burden in advanced ovarian cancer: a UK real-world survey of healthcare professionals and patients
Laura A. Tookman, Clare Green, Katy Leonard, et al.
Future Oncology (2024), pp. 1-17
Open Access
Laura A. Tookman, Clare Green, Katy Leonard, et al.
Future Oncology (2024), pp. 1-17
Open Access
Organoids research progress in gynecological cancers: a bibliometric analysis
Bing He, Haochuan Ma, Hongbo Yu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Bing He, Haochuan Ma, Hongbo Yu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Homologous recombination deficiency (HRD) diagnostics: underlying mechanisms and new perspectives
Andrey Kechin, Maksim Koryukov, Regina Mikheeva, et al.
Cancer and Metastasis Reviews (2024) Vol. 44, Iss. 1
Closed Access
Andrey Kechin, Maksim Koryukov, Regina Mikheeva, et al.
Cancer and Metastasis Reviews (2024) Vol. 44, Iss. 1
Closed Access
The prognostic and predictive value of homologous recombination deficiency status in patients with advanced stage epithelial ovarian carcinoma after first-line platinum-based chemotherapy
Yiqing Xu, Yi-Ju Amy Chen, Yunhong Wu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Yiqing Xu, Yi-Ju Amy Chen, Yunhong Wu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Role of poly-ADP-ribose polymerase inhibitors after brain progression in platinum-sensitive ovarian cancer: a case report and review of the literature
Gonzalo Lendínez-Sánchez, Tamara Díaz-Redondo, Marcos Iglesias‐Campos, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Gonzalo Lendínez-Sánchez, Tamara Díaz-Redondo, Marcos Iglesias‐Campos, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
